Clinical epidemiology and case fatality due to antimicrobial resistance in Germany: a systematic review and meta-analysis, 1 January 2010 to 31 December 2021.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
05 2023
Historique:
medline: 22 5 2023
pubmed: 18 5 2023
entrez: 18 5 2023
Statut: ppublish

Résumé

BackgroundAntimicrobial resistance (AMR) is of public health concern worldwide.AimWe aimed to summarise the German AMR situation for clinicians and microbiologists.MethodsWe conducted a systematic review and meta-analysis of 60 published studies and data from the German

Identifiants

pubmed: 37199987
doi: 10.2807/1560-7917.ES.2023.28.20.2200672
pmc: PMC10197495
doi:

Substances chimiques

Anti-Bacterial Agents 0
Fluoroquinolones 0
Cephalosporins 0

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS One. 2016 Jul 21;11(7):e0158039
pubmed: 27442425
Emerg Microbes Infect. 2022 Dec;11(1):443-451
pubmed: 35034585
J Antimicrob Chemother. 2021 Mar 12;76(4):920-929
pubmed: 33501993
Clin Infect Dis. 1997 Feb;24(2):211-5
pubmed: 9114149
J Neurol Surg A Cent Eur Neurosurg. 2023 Jan;84(1):8-13
pubmed: 33583009
Diagn Microbiol Infect Dis. 2020 Dec;98(4):115170
pubmed: 32911296
Diagn Microbiol Infect Dis. 2021 Nov;101(3):115396
pubmed: 34325178
J Clin Med. 2019 Jul 07;8(7):
pubmed: 31284699
Euro Surveill. 2021 Nov;26(45):
pubmed: 34763754
Int J Antimicrob Agents. 2020 Jun;55(6):105959
pubmed: 32325200
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Jpn J Infect Dis. 2021 Mar 24;74(2):87-96
pubmed: 32863357
Antimicrob Resist Infect Control. 2021 Mar 1;10(1):45
pubmed: 33648594
Eur J Pediatr. 2020 Nov;179(11):1769-1777
pubmed: 32447562
Int J Low Extrem Wounds. 2023 Mar;22(1):63-71
pubmed: 33745353
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Nov;55(11-12):1370-6
pubmed: 23114435
Antimicrob Resist Infect Control. 2020 Jan 31;9(1):22
pubmed: 32005223
J Burn Care Res. 2013 Nov-Dec;34(6):649-58
pubmed: 23817000
J Glob Antimicrob Resist. 2020 Jun;21:76-77
pubmed: 32205265
Int J Med Microbiol. 2021 Feb;311(2):151477
pubmed: 33524636
J Clin Epidemiol. 2012 Sep;65(9):934-9
pubmed: 22742910
J Antimicrob Chemother. 2021 Dec 24;77(1):38-48
pubmed: 34529777
J Infect Public Health. 2020 Feb;13(2):204-210
pubmed: 31420314
Am J Infect Control. 2013 Sep;41(9):778-81
pubmed: 23453393
Sci Rep. 2021 Nov 15;11(1):22265
pubmed: 34782684
Dtsch Arztebl Int. 2020 Oct 9;117(41):679-686
pubmed: 33357337
Infection. 2014 Dec;42(6):991-7
pubmed: 25100555
Int J Med Microbiol. 2021 May;311(4):151507
pubmed: 33915347
Nat Rev Dis Primers. 2018 May 31;4:18033
pubmed: 29849094
Euro Surveill. 2015;20(46):
pubmed: 26607355
Sci Rep. 2021 Apr 15;11(1):8309
pubmed: 33859304
PLoS One. 2015 Sep 23;10(9):e0138895
pubmed: 26398276
Dtsch Arztebl Int. 2018 Jul 23;115(29-30):494-500
pubmed: 30135009
Pediatr Infect Dis J. 2021 Mar 1;40(3):255-259
pubmed: 33538544
Antimicrob Resist Infect Control. 2018 Jun 5;7:71
pubmed: 29992016
PLoS One. 2021 Jan 20;16(1):e0244413
pubmed: 33471826
J Antimicrob Chemother. 2020 Aug 1;75(8):2076-2086
pubmed: 32449913
Antibiotics (Basel). 2021 Jul 29;10(8):
pubmed: 34438971
Burns. 2013 May;39(3):404-12
pubmed: 23313016
Euro Surveill. 2019 Aug;24(33):
pubmed: 31431208
J Antimicrob Chemother. 2021 Jun 18;76(7):1698-1702
pubmed: 33855441
Bone Joint J. 2021 Jun;103-B(6 Supple A):171-176
pubmed: 34053285
J Infect. 2019 Mar;78(3):215-219
pubmed: 30658080
Cell J. 2019 Jan;20(4):604-607
pubmed: 30124010
Antibiotics (Basel). 2021 Mar 19;10(3):
pubmed: 33808878
Antimicrob Resist Infect Control. 2019 Aug 28;8:147
pubmed: 31485325
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Oct;61(10):1310-1361
pubmed: 30229318
Ann Hematol. 2018 Nov;97(11):2225-2234
pubmed: 29974230
Biometrics. 1985 Mar;41(1):55-68
pubmed: 4005387
J Infect. 2017 Mar;74(3):248-259
pubmed: 28017826
Infection. 2018 Jun;46(3):325-331
pubmed: 29368165
Euro Surveill. 2021 Aug;26(31):
pubmed: 34355690
BMC Infect Dis. 2017 Oct 16;17(1):685
pubmed: 29037164
Antimicrob Agents Chemother. 2020 Mar 24;64(4):
pubmed: 32015035
Int J Surg. 2019 Oct;70:63-69
pubmed: 31437641
Antimicrob Resist Infect Control. 2018 Apr 24;7:54
pubmed: 29760912
Lancet Planet Health. 2018 Sep;2(9):e398-e405
pubmed: 30177008
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
BMC Infect Dis. 2013 Nov 01;13:515
pubmed: 24176052
Prim Care. 2018 Sep;45(3):467-484
pubmed: 30115335
Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2497-511
pubmed: 22573360
Antimicrob Resist Infect Control. 2019 Oct 21;8:159
pubmed: 31649816
Eur J Med Res. 2010 Nov 30;15(12):514-24
pubmed: 21163726
Antimicrob Resist Infect Control. 2018 Jan 5;7:1
pubmed: 29312658
Eur J Microbiol Immunol (Bp). 2019 Oct 16;9(4):124-130
pubmed: 31934364
BMC Infect Dis. 2018 Aug 6;18(1):371
pubmed: 30081842
Drugs. 2007;67(3):351-68
pubmed: 17335295
Diagn Microbiol Infect Dis. 2019 Feb;93(2):125-130
pubmed: 30266398
Emerg Infect Dis. 2018 Oct;24(10):1934-1936
pubmed: 30226179
Clin Microbiol Infect. 2020 Oct;26(10):1416.e1-1416.e4
pubmed: 32619735
Microb Genom. 2021 Oct;7(10):
pubmed: 34693903
Antimicrob Resist Infect Control. 2018 Nov 14;7:133
pubmed: 30459945
GMS Infect Dis. 2017 Jan 27;5:Doc02
pubmed: 30671324
Front Microbiol. 2021 Jun 02;12:676108
pubmed: 34149666
J Infect Dis. 2021 Oct 28;224(8):1398-1404
pubmed: 33592101
Ann Hematol. 2019 Mar;98(3):763-773
pubmed: 30666433
BMC Infect Dis. 2019 Dec 30;19(1):1091
pubmed: 31888581
Antimicrob Resist Infect Control. 2021 Sep 8;10(1):132
pubmed: 34493334
Int J Antimicrob Agents. 2019 Mar;53(3):261-267
pubmed: 30412736
J Epidemiol Community Health. 2013 Nov 1;67(11):974-8
pubmed: 23963506
Emerg Microbes Infect. 2020 Dec;9(1):1180-1193
pubmed: 32498615
Front Microbiol. 2021 May 31;12:664199
pubmed: 34135877

Auteurs

Maria Rödenbeck (M)

Institute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.

Olaniyi Ayobami (O)

Unit for Healthcare Associated Infections, Surveillance of Antimicrobial Resistance and Consumption, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Tim Eckmanns (T)

Unit for Healthcare Associated Infections, Surveillance of Antimicrobial Resistance and Consumption, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Mathias W Pletz (MW)

Institute for Infectious Diseases and Infection Control, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.

Jutta Bleidorn (J)

Institute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.

Robby Markwart (R)

InfectoGnostics Research Campus Jena, Jena, Germany.
Institute of General Practice and Family Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH